Close

Axsome Therapeutics (AXSM) PT Lowered to $123 at RBC Capital

February 21, 2024 6:51 AM EST
Get Alerts AXSM Hot Sheet
Price: $74.67 -1.78%

Rating Summary:
    20 Buy, 0 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 9 | Down: 4 | New: 10
Join SI Premium – FREE
RBC Capital analyst Leonid Timashev lowered the price target on Axsome Therapeutics (NASDAQ: AXSM) to $123.00 (from $126.00) while maintaining a Outperform rating.

You May Also Be Interested In





Related Categories

Analyst PT Change